search
Back to results

The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Phase 3
Locations
Sri Lanka
Study Type
Interventional
Intervention
Kothala Himbutu Biscuit
Placebo Biscuit
Sponsored by
Rajarata University, Sri Lanka
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes Mellitus focused on measuring biscuit containing Salacia reticulate, randomised controlled trial

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Type 2 diabetes for minimum period of 6 months
  2. Aged between 30 and 65 years
  3. Stable glycaemic control over the preceding 2-3 months. They will be initially selected from a range of HBA1C varying from 6.5 - 14 and the individual subject should not have a variation of >20% between the previous HBA1C and the HBA1C done at the commencement of the study

Exclusion Criteria:

  1. Chronic kidney disease with estimated Glomerular filtration rate less than 30ml/hour
  2. Severe valvular heart disease or heart failure.
  3. Those on Insulin therapy
  4. Severe liver disease (AST > 10 X times the upper limit)

Sites / Locations

  • Teaching Hospital Anuradhapura

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Kothala Himbutu biscuit

placebo biscuit

Arm Description

A biscuit containing Kothala Himbutu (Salacia reticulata) extract. This biscuit is available in the supermarkets. Four biscuits twice a day for 3 months.

An identical biscuit without the herbal extract from Kothala Himbutu (Salacia reticulate)

Outcomes

Primary Outcome Measures

Glycosylated Haemoglobin
HBA1c were analyzed at a centrally accredited lab using ion exchange high performance liquid chromatography standardized to NGSP

Secondary Outcome Measures

Liver Adverse Effects
liver functions are described in the table below with higher liver enzymes suggesting injury to the liver.
Renal Adverse Effects -1
Renal functions are described in the table below with Lower estimated Glomerular Filtration Rate (eGFR) suggesting injury to the kidney.
Renal Adverse Effects - 2
Renal functions are described in the table below with higher serum creatinine suggesting injury to the kidney.

Full Information

First Posted
November 7, 2014
Last Updated
May 2, 2019
Sponsor
Rajarata University, Sri Lanka
search

1. Study Identification

Unique Protocol Identification Number
NCT02290925
Brief Title
The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study
Official Title
The Effect of a Biscuit Containing the Extract of Salacia Reticulata on Glycaemia in Patients With Type 2 Diabetes Mellitus Randomized Triple Blind Placebo Controlled Two Period Two Sequence Crossover Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
April 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rajarata University, Sri Lanka

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators intend to conduct a triple blind randomized clinical trial to investigate the effect of a biscuit containing herbal extract, available in the market on the fasting blood sugar control in patients with diabetes mellitus and also to find out whether there are any side effects on other vital organs such as kidneys and liver.
Detailed Description
The effect of a biscuit containing the extract of Salacia reticulata (Kothala Himbutu) on the reduction of blood glucose levels in patients with Type 2 Diabetes Mellitus. A single center randomized triple blind placebo controlled two period two sequence crossover clinical trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
biscuit containing Salacia reticulate, randomised controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Model Description
Patients with diabetes were screened and Type I Diabetes was excluded. The minimum run-in period was eight weeks and if the variability of HbA1c is more than 20%, excluded, to exclude patients with fluctuating glycaemia. As this is a crossover trial some degree of stability of the glycemic control is necessary to prevent excessive variation of HbA1c interfering with the study outcome. Participants were randomized to receive the KH or placebo biscuit. Oral hypoglycemic was continued and adjusted. Participants consumed KH or placebo biscuit for a period of 3 months as mid-morning and afternoon snack. Subsequently in the washout period of 1 month the participants did not consumed any biscuits. After, crossing over they continued biscuits for another 3 months. HbA1c was done at recruitment, after run-in period, at 3 months and on completion of the study. When there was deterioration of the glycaemic control patient was prescribed insulin, and withdrawn from the study.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Randomization code (A or B) was made using a computer and inserted in a sealed, serially numbered, opaque envelopes. Participants were given a serial number after run-in period. Assistant opened the envelope and assigned the patient to either biscuit A or B. The manufacturers held randomization code. Investigators, patients and those assessing the analysis were masked to the group outcome. Both Kothala Himbutu (KH) and placebo biscuits are identical in size, wrapped in same cover, and packed in identical boxes. The investigators tasted both biscuits and KH biscuits were slightly darker with the same taste. The study product is available in the market. Patients participating in the trial were asked about prior consumption of KH biscuits bought from the market (to exclude contamination). At the end of each period patients were asked whether they could assume the type of biscuit (KH biscuit or placebo) given to them and their preference for the type.
Allocation
Randomized
Enrollment
133 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Kothala Himbutu biscuit
Arm Type
Experimental
Arm Description
A biscuit containing Kothala Himbutu (Salacia reticulata) extract. This biscuit is available in the supermarkets. Four biscuits twice a day for 3 months.
Arm Title
placebo biscuit
Arm Type
Placebo Comparator
Arm Description
An identical biscuit without the herbal extract from Kothala Himbutu (Salacia reticulate)
Intervention Type
Drug
Intervention Name(s)
Kothala Himbutu Biscuit
Other Intervention Name(s)
Biscuit contining Salacia reticulata extract, Kothala Himbutu Biscuit manufactured by Ceylon Biscuits Ltd, Munchee Kothala Himbutu biscuit
Intervention Description
Kothala Himbutu biscuit (containing Salacia reticulata extract) as a snack. This herb has been used by traditional physicians to control blood sugar.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo Biscuit
Other Intervention Name(s)
Biscuit, Munchee biscuit
Intervention Description
Placebo biscuit without the herbal extract of Kothala Himbutu (Salacia reticulate)
Primary Outcome Measure Information:
Title
Glycosylated Haemoglobin
Description
HBA1c were analyzed at a centrally accredited lab using ion exchange high performance liquid chromatography standardized to NGSP
Time Frame
After 3 months and after 7 months (there is one month wash over period as this is a cross over trial)
Secondary Outcome Measure Information:
Title
Liver Adverse Effects
Description
liver functions are described in the table below with higher liver enzymes suggesting injury to the liver.
Time Frame
Baseline, after 3 months, and after 7 months
Title
Renal Adverse Effects -1
Description
Renal functions are described in the table below with Lower estimated Glomerular Filtration Rate (eGFR) suggesting injury to the kidney.
Time Frame
baseline, after 3 months and after 7 months
Title
Renal Adverse Effects - 2
Description
Renal functions are described in the table below with higher serum creatinine suggesting injury to the kidney.
Time Frame
Baseline, after 3 months, and after 7 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 diabetes for minimum period of 6 months Aged between 30 and 65 years Stable glycaemic control over the preceding 2-3 months. They will be initially selected from a range of HBA1C varying from 6.5 - 14 and the individual subject should not have a variation of >20% between the previous HBA1C and the HBA1C done at the commencement of the study Exclusion Criteria: Chronic kidney disease with estimated Glomerular filtration rate less than 30ml/hour Severe valvular heart disease or heart failure. Those on Insulin therapy Severe liver disease (AST > 10 X times the upper limit)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nadeesha Wickramasinghe, BSc
Organizational Affiliation
Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka
Official's Role
Study Director
Facility Information:
Facility Name
Teaching Hospital Anuradhapura
City
Anuradhapura
State/Province
North Central Province
ZIP/Postal Code
50000
Country
Sri Lanka

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual Patient Data (IPD) will be available for researchers.
IPD Sharing Time Frame
10 years after end of the study (March 2019)
IPD Sharing Access Criteria
Any qualified researcher should submit the protocol and get the ERC clearence from institutional IRB (Ethics Review Committee, Faculty of Medicine & Allied Science, Rajarata University of Sri Lanka). After that they need to come to an written agreement with the researchers to analyze the data.

Learn more about this trial

The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study

We'll reach out to this number within 24 hrs